Nuzenio

Fosun Pharma

Fosun Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 17:46:44 GMTFosun Pharma (02196): Levosalbutamol Hydrochloride Nebulizer Solution Receives Marketing Authorization - Moomoo
Wed, 05 Aug 2026 16:05:13 GMTExpedition raises USD 115m to advance Fosun-sourced DPP1 inhibitor - AllSci
Tue, 04 Aug 2026 12:58:57 GMTShanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF) Q4 2023 Earnings Report - Results, Call & Slides - TipRanks
Tue, 04 Aug 2026 12:43:34 GMTShanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF) Q1 2024 Earnings Report - Results, Call & Slides - TipRanks
Tue, 04 Aug 2026 10:26:00 GMTFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug - The Globe and Mail
Mon, 03 Aug 2026 11:34:26 GMTFosun Pharma Units Get Registration Nod for Two Drugs in China - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fosun Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.